Biotech Investor Forms New Company | November 17, 2008 Issue - Vol. 86 Issue 46 | Chemical & Engineering News
Volume 86 Issue 46 | p. 27 | Concentrates
Issue Date: November 17, 2008

Biotech Investor Forms New Company

Department: Business

FirstPoint Biotech, a San Francisco-based venture capital firm, will acquire a majority interest in London's RCP Therapeutics, a biopharmaceutical company that focuses on nanotechnology and regenerative medicine. As part of the $10 million investment, FirstPoint will establish a separate company to support RCP's R&D in "cosmeceutical" technologies. The remaining firm, to be called FirstPoint RCP Therapeutics, will continue its R&D in regenerative medicine.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment